Oncoliq

We imagine a future where science is built through diverse perspectives, better questions, and research that truly reflects the world we live in.

On this International Day of Women and Girls in Science, we reaffirm our commitment to that future. One shaped by more women, stronger science, and earlier detection.

The probability of developing invasive cancer over a lifetime is 1 in 3. However, the outcome of that story is within our control.

We used to live in a world of reactive detection, waiting for the body to "announce" a problem through symptoms. By then, the disease has often advanced, leading to aggressive treatments and lower survival rates.

Today, we are entering the era of proactive detection. By listening to molecular signals like miRNAs, we can identify cancer at its very origin. Detecting cancer early changes the human experience of the disease, making a 90% survival rate a reachable reality.

The path of knowledge is the path to survival.

One goal unites us: a world where cancer is caught in time and treated with humanity. But we know that the strength to face this journey comes from being truly understood.

This World Cancer Day, we celebrate the power of people-centred care and early prevention.

Because while the fight is global, the support must be as unique as you are. 🎗️✨

Every healthy cell in your body is a team player, following a precise genetic "rulebook" to grow and work. But cancer is different. It starts when a cell stops listening, changes its shape, and begins to follow its own rules.

While these cells try to hide, they leave traces. At Oncoliq, we specialize in finding those specific molecular fingerprints (miRNAs) circulating in the blood.

Our goal is to detect them before they spread, when cancer is still asymptomatic and at its most treatable stage.

Catching it early makes all the difference.

Cervical cancer is preventable and treatable. And yet, 348.000 women die from it every year, making it the fourth deadliest cancer among women.

But early detection can increase the 5-year survival rate to 91%. Early screening is key to saving lives.

At Oncoliq, we believe early detection should be accessible to everyone, because timing can make all the difference.

By combining vaccination, early screening, and effective treatment, we can significantly reduce the global burden of cervical cancer.

Detect early. Save lives.

Biomarkers are tiny molecules that provide crucial information about your body.

In the case of cancer, microRNAs act as early warning signals, revealing cancerous changes before they become visible or cause symptoms. These molecules are stable and easily detectable in body fluids like blood, saliva, or urine.

At Oncoliq, we use these to detect cancer at its earliest stages with a simple, non-invasive blood test, giving patients a better chance for successful treatment.

Early detection saves lives. 🩸✨

2025 has been a year of milestones and gratitude.

As we close out this chapter, we reflect on how far we've come and the incredible people who have made it possible. From our dedicated team to the hospitals and clinics supporting us, and the exciting recognition we've received, we're ready to take 2026 to new heights. 🌟

Thanks to everyone who’s been part of this journey. Together, we’re advancing early cancer detection and making a real impact. Let’s continue to grow, innovate, and change lives in the year ahead.

Here’s to a future full of possibilities. 💙

At Oncoliq, we’re combining cutting-edge AI with molecular biology to detect cancer earlier, using just a simple blood test. 🩸

By identifying microRNAs, tiny molecules that change when cancer develops, our AI can spot patterns that are too subtle for traditional methods. This helps us predict cancer even before symptoms appear, improving the chances of early treatment. 💡

But while AI is a powerful tool, it’s the knowledge of experts that turns this technology into life-saving action.

Together, we can make early cancer detection smarter, more accessible, and more precise. 💙

In the fight against cancer, every diagnosis counts. That’s why understanding the science behind sensitivity and specificity is crucial. These two key factors define how well a test can identify the disease and avoid false results.

At Oncoliq, we combine 92% sensitivity and 71% specificity to offer a reliable, non-invasive test that detects cancer at its earliest, most treatable stages.

🔗 Learn more about how Oncoliq is changing the future of cancer detection. Link in bio.

Today, we reflect on the importance of listening to what the body can’t yet say.

This World Pancreatic Cancer Day 🌍 we reaffirm our mission to make early detection accessible to everyone.

🔬 Science is driven by one common goal: to understand the world so we can improve it.

It is not an exclusive territory: It’s a shared tool that grows stronger when it serves people.

Today, we celebrate the power of knowledge to create real impact, to reduce inequalities, drive progress, and build fairer societies. 🌍

At Oncoliq, we believe in a kind of science that goes beyond the lab.

A science rooted in accessibility, equity, and opportunity for all.

💙 Doing science with purpose is also a way of building peace.